Abstract: A display substrate includes a plurality of pixel driving circuits and data signal line groups. A column of pixel driving circuits are divided into n pixel driving circuit groups, and a data signal line group is electrically connected to a column of pixel driving circuits. Two data signal line groups respectively electrically connected to an m-th column of pixel driving circuits and an (m+1)-th column of pixel driving circuits include a first data signal line and a second data signal line, located between the two columns of pixel driving circuits. Multiple anode transfer lines electrically connected to the (m+1)-th column of pixel driving circuits include a first anode transfer line including a first anode transfer portion in a same layer as a data signal line. In a row direction, the first anode transfer portion is located between the first data signal line and the second data signal line.

Abstract: An array substrate includes a substrate and pixel circuits disposed on the first substrate. A pixel circuit includes a first light-emitting control transistor and a second light-emitting control transistor. The array substrate further includes a first light-emitting control signal line and a second light-emitting control signal line. The first light-emitting control signal line is electrically connected to a gate of the first light-emitting control transistor. The second light-emitting control signal line is electrically connected to a gate of the second light-emitting control transistor. The array substrate further includes conductive layers. The first light-emitting control signal line and the second light-emitting control signal line are electrically insulated. The first light-emitting control signal line and the second light-emitting control signed line are located in different conductive layers.

Abstract: The invention discloses a solid dispersion, a pharmaceutical preparation, a preparation method and an application thereof. The solid dispersion of the invention comprises carriers and active constituents, which is a compound as shown in formula (I) and/or a pharmaceutically acceptable salt thereof; The carrier is “homopolymer and copolymer of N-vinyl lactam” and/or pH-dependent cellulose derivatives. The preparation of the invention comprises the solid dispersion, fillers and disintegrating agents. The solid dispersion of the invention has good dissolution and significantly improves the solubility of effective constituents. The preparation can effectively improve the bioavailability of Bcl-2 inhibitor, has good dissolution and stability, and can improve the safety of a medication.

Abstract: A structure for overcoming polarity reversal in a dual-ferroelectric-crystal-paired electro-optic device is provided. The structure is in a shape of a parallelogram and includes a first crystal, a second crystal, a first reflector and a second reflector, where the first crystal, the second crystal, the first reflector, and the second reflector are all provided on the same metal plate, the first crystal and the first reflector are located at the upper side of the parallelogram, and the second crystal and the second reflector are located at the lower side of the parallelogram, the first reflector reflects the laser light transmitted through the first crystal to the second reflector at the lower side of the parallelogram, and the second reflector reflects the light to the light-transmitting face of the second crystal. In the present disclosure, a voltage is applied only to the first crystal in the spontaneous polarization direction.

Abstract: In an array substrate, a control electrode of a driving transistor, a second electrode of a compensation transistor and a second electrode of a first reset transistor are electrically connected to a first conductive connection portion, and a first electrode of the driving transistor and a second electrode of a data writing transistor are electrically connected to a second conductive connection portion. An orthographic projection of a first conductive portion of the first conductive connection portion overlaps with an orthographic projection of a first scan signal line, and overlaps with an orthographic projection of a second scan signal line. A first shielding layer includes a first shielding pattern; in a thickness direction of the substrate, the first shielding pattern is located between the first scan signal line and the first conductive portion, and/or the first shielding pattern is located between the second scan signal line and the first conductive portion.

Abstract: In an array substrate, a control electrode of a driving transistor, a second electrode of a compensation transistor and a second electrode of a first reset transistor are electrically connected to a first conductive connection portion, and a first electrode of the driving transistor and a second electrode of a data writing transistor are electrically connected to a second conductive connection portion. An orthographic projection of a first conductive portion of the first conductive connection portion overlaps with an orthographic projection of a first scan signal line, and overlaps with an orthographic projection of a second scan signal line. A first shielding layer includes a first shielding pattern; in a thickness direction of the substrate, the first shielding pattern is located between the first scan signal line and the first conductive portion, and/or the first shielding pattern is located between the second scan signal line and the first conductive portion.

Abstract: An array substrate includes a substrate and pixel circuits disposed on the first substrate. A pixel circuit includes a first light-emitting control transistor and a second light-emitting control transistor. The array substrate further includes a first light-emitting control signal line and a second light-emitting control signal line. The first light-emmitting control signal line is electrically connected to a gate of the first light-emitting control transistor. The second light-emitting control signal line is electrically connected to a gate of the second light-emitting control transistor. The array substrate further includes conductive layers. The first light-emitting control signal line and the second light-emitting control signal line are electrically insulated. The first light-emitting control signal line and the second light-emitting control signed line are located in different conductive layers.

Abstract: In an array substrate, a control electrode of a driving transistor, a second electrode of a compensation transistor and a second electrode of a first reset transistor are electrically connected to a first conductive connection portion, and a first electrode of the driving transistor and a second electrode of a data writing transistor are electrically connected to a second conductive connection portion. An orthographic projection of a first conductive portion of the first conductive connection portion overlaps with an orthographic projection of a first scan signal line, and overlaps with an orthographic projection of a second scan signal line. A first shielding layer includes a first shielding pattern; in a thickness direction of the substrate, the first shielding pattern is located between the first scan signal line and the first conductive portion, and/or the first shielding pattern is located between the second scan signal line and the first conductive portion.

Abstract: The present invention discloses a domain wall straightening method of a periodically poled ferroelectric crystal. In the present invention, by testing a piezoelectric coefficient of a poled sample, the poling condition of the sample can be judged nondestructively, and the region of uniform poling can be screened out. At the same time, according to the calculation result of a duty cycle, the continuation or stop of poling, and the re-poling after single domain can be judged. The flatness of the domain wall is judged through the change quantity of the piezoelectric coefficient, and the size and the duration of the poling voltage are adjusted in time, to accurate control the poling process, so as to obtain high-quality periodically poled crystals.

Abstract: The present invention discloses a domain wall straightening method of a periodically poled ferroelectric crystal. In the present invention, by testing a piezoelectric coefficient of a poled sample, the poling condition of the sample can be judged nondestructively, and the region of uniform poling can be screened out. At the same time, according to the calculation result of a duty cycle, the continuation or stop of poling, and the re-poling after single domain can be judged. The flatness of the domain wall is judged through the change quantity of the piezoelectric coefficient, and the size and the duration of the poling voltage are adjusted in time, to accurate control the poling process, so as to obtain high-quality periodically poled crystals.

Abstract: The present invention relates to a pharmaceutical composition containing alkynyl compound, a preparation method thereof and its application. The present invention discloses a pharmaceutical composition comprising an active pharmaceutical ingredient and an available pharmaceutical excipient; The active pharmaceutical ingredient is 3-((1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-benzamide, or its pharmaceutical acceptable salt; The available pharmaceutical excipients includes diluents and lubricants. The pharmaceutical composition can effectively improve the bioavailability of the alkynyl compound, has good dissolution and stability, and improve the drug safety.

Abstract: A bug zapper includes a housing assembly, a bug killing assembly, an LED circuit board, and a collection box. The housing assembly includes a main housing and a base. The main housing defines an accommodating space therein. Through holes communicated with the accommodating space are defined on the main housing. The base is annularly disposed and defines a central through hole and is connected to a bottom portion of the main housing. The base defines an inner side surface facing the central through hole. The bug killing assembly is disposed in the accommodating space. The LED circuit board is disposed on the base. The collection box is detachably mounted on the inner side surface of the base. The collection box defines a collection cavity disposed below the bug killing assembly. The bug zapper is able to illuminate while killing bugs.

Abstract: The present invention relates to a pharmaceutical composition containing alkynyl compound, a preparation method thereof and its application. The present invention discloses a pharmaceutical composition comprising an active pharmaceutical ingredient and an available pharmaceutical excipient; The active pharmaceutical ingredient is 3-((1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-benzamide, or its pharmaceutical acceptable salt; The available pharmaceutical excipients includes diluents and lubricants. The pharmaceutical composition can effectively improve the bioavailability of the alkynyl compound, has good dissolution and stability, and improve the drug safety.

Abstract: The invention discloses a solid dispersion, a pharmaceutical preparation, a preparation method and an application thereof. The solid dispersion of the invention comprises carriers and active constituents, which is a compound as shown in formula (I) and/or a pharmaceutically acceptable salt thereof; The carrier is “homopolymer and copolymer of N-vinyl lactam” and/or pH-dependent cellulose derivatives. The preparation of the invention comprises the solid dispersion, fillers and disintegrating agents. The solid dispersion of the invention has good dissolution and significantly improves the solubility of effective constituents. The preparation can effectively improve the bioavailability of Bcl-2 inhibitor, has good dissolution and stability, and can improve the safety of a medication.

Abstract: The present invention relates to a pharmaceutical composition containing alkynyl compound, a preparation method thereof and its application. The present invention discloses a pharmaceutical composition comprising an active pharmaceutical ingredient and an available pharmaceutical excipient; The active pharmaceutical ingredient is 3-((1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-benzamide, or its pharmaceutical acceptable salt; The available pharmaceutical excipients includes diluents and lubricants. The pharmaceutical composition can effectively improve the bioavailability of the alkynyl compound, has good dissolution and stability, and improve the drug safety.